Phase III trials of new oral anticoagulants in the acute treatment and secondary prevention of VTE: comparison and critique of study methodology and results.

Adv Ther · 2014 · PMC4033807 · PMID 24821599

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

With regard to bleeding rates during acute treatment of patients with VTE, the results varied by the outcome measured, however, both standard measurements, described below, showed a trend to reduction for all four NOACs.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.